Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
221.00    3.00 (1.38%)
Bid:
220.00
Ask:
222.00
Spread: 2.00 (0.909%)
Market Cap: £150.69m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Update on Share Buyback Programme

Today 07:01

RNS Number : 0528M
Helios Underwriting Plc
13 July 2026
 

13 July 2026

 HELIOS UNDERWRITING PLC

 ("Helios ", or the "Company")

 Update on Share Buyback Programme

 

Helios Underwriting plc, the only publicly traded company offering access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, announces an amendment to its share buyback programme in the Company's ordinary shares of 10 pence each ("Ordinary Shares"), launched with Peel Hunt LLP ("Peel Hunt") on 9 April 2026 to return up to a maximum aggregate consideration of £2,000,000 to shareholders (the "Amended Share Buyback Programme").

The Company has to date relied upon the safe harbour conditions for trading set out in Article 5 of the Market Abuse Regulation (596/2014), as it forms part of assimilated law in the UK by virtue of the European Union (Withdrawal) Act 2018 and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019, and in the Commission Delegated Regulation (EU) 2016/1052, as it forms part of assimilated law in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019 (together, "MAR"). However, due to the illiquidity of the Company's Ordinary Shares, the safe harbour volume parameter has constrained its ability to purchase Ordinary Shares within an efficient and practicable timeframe and the Company has now decided to amend its agreement with Peel Hunt and conduct the Amended Share Buyback Programme on the following basis:

• Peel Hunt will continue to manage the purchases on a discretionary basis, purchasing Ordinary Shares within certain pre-set parameters and making its trading decisions independently of, and uninfluenced by, the Company. Purchases may therefore continue during any closed periods of the Company.

• The Amended Share Buyback Programme will be executed in accordance with the authority to repurchase Ordinary Shares granted by the Company's shareholders at the annual general meeting ("AGM") held on 22 June 2026, being authority to repurchase up to a maximum of 6,942,081 Ordinary Shares (the "General Authority").

• In accordance with the General Authority, the maximum price to be paid per Ordinary Share acquired by the Company pursuant to the Amended Share Buyback Programme will be no more than the higher of (i) 105% of the average middle market closing price of an Ordinary Share on AIM for the five business days preceding the date of purchase and (ii) the higher of the price of the last independent trade and the highest current independent purchase bid for an Ordinary Share on the trading venue where the purchase is carried out; and in any event no more than the net asset value per share of the Company.

• The purchased Ordinary Shares will be held by the Company in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

• The Amended Share Buyback Programme will continue from the date of this announcement until the earlier of (i) the maximum aggregate consideration of £2,000,000 having been reached and (ii) the expiration of the General Authority or, if earlier, the conclusion of the Company's next AGM.

• Shareholders should be aware that the Amended Share Buyback Programme may on any given trading day represent a significant portion of the daily traded volume in the Company's Ordinary Shares on AIM, and the Company expects daily volumes to exceed 25% of the average daily traded volume in the Ordinary Shares over the 20 trading days preceding a purchase. Accordingly, the Company may not benefit from the exemption contained in Article 5(1) of MAR.

• Outside of the above, the Amended Share Buyback Programme will be conducted in accordance with the other safe harbour parameters as prescribed by MAR insofar as possible.

• As at 10 July 2026, the Company's total issued share capital consisted of 76,040,011 Ordinary Shares, each carrying one voting right, and the Company held 5,945,159 Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 70,094,852, which figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

• The Company confirms that it currently has no unpublished inside information.

 

For further information contact:

Helios Underwriting plc

Louis Tucker - Chief Executive Officer

+44 (0)20 3965 6441

Adhiraj Maitra - Director of Finance and Operations

+44 (0)20 3743 2114

Peel Hunt (Nomad, Broker and Financial Adviser)

Dan Webster / Andrew Buchanan / Martin Frowde

+44 (0)20 7418 8900

Singer Capital Markets (Joint Broker)

Charles Leigh-Pemberton / Russell Cook / James Todd

+44 (0)20 7496 3000

FTI Consulting

Ed Berry

+44 (0)7703 330 199

Christian Harte

+44 (0)7974 288 763

   About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKBBPKBKBKOD
Date   Source Headline
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
29th May 20257:06 amRNSDirectorate Change
29th May 20257:03 amRNSCompany Announcement
29th May 20257:00 amRNSHelios Underwriting 2024 Preliminary Results
20th May 20257:00 amRNSNotice of Results and Change in Accounting
10th Apr 20253:41 pmRNSDirector Shareholding
9th Apr 202512:22 pmRNSDirector/PDMR Shareholding
8th Apr 20257:02 amRNSShare Repurchase Programme - 2025
8th Apr 20257:00 amRNSNet Asset Value as at 31 December 2024
13th Mar 20257:00 amRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSDirectorate Change
18th Dec 20247:00 amRNS2025 Capacity Update
15th Nov 20247:00 amRNSCapacity Value Update
3rd Oct 20242:08 pmRNSInvestor Presentation via Investor Meet Company
30th Sep 20247:00 amRNSGrant of LTIP Awards
27th Sep 20247:00 amRNSHalf Year Results
23rd Sep 20247:00 amRNSTR-1: Notification of major holdings
30th Aug 20247:00 amRNSAppointment of Non-Executive Director
1st Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20247:00 amRNSNet Asset Value as at 31 March 2024
24th Jul 20245:36 pmRNSHolding(s) in Company
23rd Jul 20245:05 pmRNSCompletion of Share Buy-Back
17th Jul 20248:50 amRNSDirector/PDMR Shareholding
12th Jul 20247:00 amRNSIssue of Equity
10th Jul 20247:00 amRNSResults of Scrip Dividend Election
9th Jul 20247:00 amRNSShare Repurchase Programme - 2024
1st Jul 20247:00 amRNSDirectorate Change
28th Jun 202411:25 amRNSResults of Annual General Meeting
28th Jun 20247:00 amRNSAGM Statement
19th Jun 20247:00 amRNSShare Repurchase Programme
17th Jun 20247:00 amRNSGrant of LTIP Awards
14th Jun 20247:00 amRNSScrip Dividend Reference Price
7th Jun 20247:00 amRNSDirectorate Change
4th Jun 20247:00 amRNSPosting of Annual Report and Notice of AGM
3rd Jun 20243:19 pmRNSDirector's Shareholding
30th May 20247:00 amRNSFinal results for the year ended 31 December 2023
22nd Apr 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.